Connect with us

JAMMU & KASHMIR

Blood pressure medicines don’t increase risk of COVID: DAK | KNO

Published

on

kno news

Srinagar, June 01 (KNO): Doctors Association Kashmir (DAK) on Monday said blood pressure medicines do not increase the risk of infection, serious illness or death from the novel coronavirus. “It is perfectly safe to continue your blood pressure medication during the Covid pandemic,” said DAK President Dr Nisar-u-Hassan in a statement issued to news agency—Kashmir News Observer (KNO) “People have apprehensions that ACE inhibitors and ARBs, two classes of drugs that are widely prescribed for high blood pressure increase the risk of Covid infection and the likelihood of severe illness among those infected with the novel virus,” he said. “ACE inhibitors include enalapril, lisinopril, captopril and other drugs with generic names ending in –pril; ARBs include Losartan, telmisartan, olmesartan and other generic drugs ending in –sartan,” he added. Dr Nisar said speculations about worse outcomes among patients on these medications during the Covid pandemic have caused widespread anxiety among patients and their care providers. Quoting three studies published in New England Journal of Medicine, Dr Nisar said no link was found between the use of blood pressure drugs and coronavirus infection. “It was also revealed that patients on these drugs faced no increase in risk of becoming severely ill with Covid infection,” he added. Dr Nisar said the articles showed no association between use of the two classes of blood pressure drugs of concern and dying from COVID-19. “In fact, some studies suggest that these drugs might reduce lung injury in people infected with the novel virus,” he said. Dr Nisar said it is vitally important to keep your blood pressure well controlled and take medication as advised. “Having high blood pressure has been associated with higher rate of dying from Covid-19,” he said. “People should stick with their blood pressure medication because high blood pressure is a risk factor for heart attack, stroke and kidney failure,” said Dr Nisar –(KNO)

Trending

TOP STORIES4 hours ago

From Displaced Roots to an Environmental Voice | KNO

TOP STORIES4 hours ago

J&K govt notifies consolidated ex-gratia relief norms for L&O disturbance victims | KNO

TOP STORIES4 hours ago

J&K proposes over 300 PG medical seats to National Medical Commission | KNO

TOP STORIES4 hours ago

Heavy rain likely in Jammu division over next 24 hours | KNO

TOP STORIES4 hours ago

Security stepped up across Srinagar ahead of Aug 15 celebrations | KNO

TOP STORIES4 hours ago

Ahead of I-Day, security forces step up vigil along LoC, border | KNO

TOP STORIES4 hours ago

Multi-tier security arrangements put in place across Kashmir ahead of I-Day: IGP Birdi | KNO

TOP STORIES5 hours ago

Macadamisation works resume in Srinagar, pace to pick up after Aug 15 | KNO

TOP STORIES5 hours ago

Apple scab threat looms over Kashmir orchards | KNO

TOP STORIES5 hours ago

‘End unnecessary suspicion of Kashmiri youth’: NC chief spokesperson urges Centre, J&K admin | KNO

TOP STORIES5 hours ago

Repora emerges as Kashmir’s ‘Grape Village’ as centuries-old cultivation thrives in Ganderbal | KNO

TOP STORIES5 hours ago

Declining chestnut yield worries Wular Lake-dependent communities | KNO

TOP STORIES5 hours ago

J&K gets Rs 261.87 cr under PMGSY in 2025-26; 2,132 habitations connected | KNO

TOP STORIES5 hours ago

Drug seizures in J&K drop to 4,977 kg in 2024, convictions rise | KNO

TOP STORIES5 hours ago

Centre allocates Rs 980 crore to J&K under PMGSY for 2026-27 | KNO

TOP STORIES5 hours ago

174 textile MSMEs shut down in J&K, 886 workers affected in three years: Centre | KNO

TOP STORIES5 hours ago

23.83 lakh women representatives trained under revamped RGSA in three years: Centre | KNO

Copyright © 2021